Stocks
SpyGlass Pharma, Inc.SGP
NASDAQHealthcareMedical Devices$24.00
Price as of · delayed, not real-time
A clinical-stage medical device company developing a sustained-release drug delivery implant for the treatment of glaucoma. Its lead candidate, the SpyGlass implant, combines a micro-invasive glaucoma surgery device with a continuous drug release mechanism, targeting the large market of patients who struggle with daily eye drop regimens. Investors track the company for its potential to disrupt the standard of care in ophthalmology and for its upcoming clinical trial readouts.
52W Range: $17.06-$32.44
Congressional Interest in SpyGlass Pharma, Inc. (SGP)
No congressional trades have been disclosed for SpyGlass Pharma, Inc. (SGP) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading SGP?
No congressional trades found for this stock.